Chang-Yuil Kang

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 9

Top Topics

Inflammatory Response

Respiratory Syndrome Coronavirus

Atopic Dermatitis

Dendritic Cells

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Mediators of inflammation

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Soojeong Chang, Kwang-Soo Shin, Bongju Park, Seowoo Park, Jieun Shin, Hyemin Park, In Kyung Jung, Jong Heon Kim, Seong Eun Bae, Jae-Ouk Kim, Seung Ho Baek, Green Kim, Jung Joo Hong, Hyungseok Seo, Erik M Volz, Chang-Yuil Kang
Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform. Proceedings of the National Academy of Sciences of the United States of America 121 (10) (2024)
Choong-Hyun Koh, Byung-Seok Kim, Chang-Yuil Kang, Yeonseok Chung, Hyungseok Seo
IL-17 and IL-21: Their Immunobiology and Therapeutic Potentials. Immune network 24 (1) (2024)
Soojeong Chang, Kwang-Soo Shin, Bongju Park, Seowoo Park, Jieun Shin, Hyemin Park, In Kyung Jung, Jong Heon Kim, Seong Eun Bae, Jae-Ouk Kim, Seung Ho Baek, Green Kim, Jung Joo Hong, Hyungseok Seo, Erik M Volz, Chang-Yuil Kang
Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform. Proceedings of the National Academy of Sciences of the United States of America 121 (10) (2024)
Soojeong Chang, Kwang-Soo Shin, Bongju Park, Seowoo Park, Jieun Shin, Hyemin Park, In Kyung Jung, Jong Heon Kim, Seong Eun Bae, Jae-Ouk Kim, Seung Ho Baek, Green Kim, Jung Joo Hong, Hyungseok Seo, Erik M Volz, Chang-Yuil Kang
Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform. Proceedings of the National Academy of Sciences of the United States of America 121 (10) (2024)
Soojeong Chang, Kwang-Soo Shin, Bongju Park, Seowoo Park, Jieun Shin, Hyemin Park, In Kyung Jung, Jong Heon Kim, Seong Eun Bae, Jae-Ouk Kim, Seung Ho Baek, Green Kim, Jung Joo Hong, Hyungseok Seo, Erik M Volz, Chang-Yuil Kang
Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform. Proceedings of the National Academy of Sciences of the United States of America 121 (10) (2024)
Choong-Hyun Koh, Byung-Seok Kim, Chang-Yuil Kang, Yeonseok Chung, Hyungseok Seo
IL-17 and IL-21: Their Immunobiology and Therapeutic Potentials. Immune network 24 (1) (2024)
Young-In Kim, Joo-Hye Song, Hyun-Jeong Ko, Mi-Na Kweon, Chang-Yuil Kang, Hans-Christian Reinecker, Sun-Young Chang
CX3CR1+ Macrophages and CD8+ T Cells Control Intestinal IgA Production. Journal of immunology (Baltimore, Md. : 1950) 201 (4) (2018)
Hyungseok Seo, Insu Jeon, Byung-Seok Kim, Myunghwan Park, Eun-Ah Bae, Boyeong Song, Choong-Hyun Koh, Kwang-Soo Shin, Il-Kyu Kim, Kiyoung Choi, Taegwon Oh, Jiyoun Min, Byung Soh Min, Yoon Dae Han, Suk-Jo Kang, Sang Joon Shin, Yeonseok Chung, Chang-Yuil Kang
IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours. Nature communications 8 (2017)
Min Jung Bae, Hye-Jeong See, Gyeyoung Choi, Chang-Yuil Kang, Dong-Hwa Shon, Hee Soon Shin
Regulatory T Cell Induced by Poria cocos Bark Exert Therapeutic Effects in Murine Models of Atopic Dermatitis and Food Allergy. Mediators of inflammation 2016 (2016)